Aptima Combo 2® assay (for CT/NG)

STIs are on the rise. Chlamydia (CT) and gonorrhea (NG) can have serious long-term consequences including pelvic inflammatory disease (PID), ectopic pregnancy and infertility.1 Accurate testing and treatment are critical to protecting sexual and reproductive health. The Aptima Combo 2® assay delivers reliable results from multiple specimen types, including self and clinician-collected vaginal swabs with the Aptima® Multitest Swab — the preferred specimen type of the CDC for CT and NG testing.

Aptima HPV +ThinPrep Cervical Health

Leading the charge in cervical disease prevention with the ThinPrep® system and Aptima® HPV assays

Hologic has remained an unwavering advocate for women’s health for more than two decades. Our goals as a company are intrinsically tied to changes in best-practices for women’s health, applying the latest findings in diagnostic medicine to the development of new products and technologies in response to the emergence of new discoveries in medicine.

Aptima Multitest Swab Specimen Collection Kit

Women’s health testing streamlined with just one swab. With innovative nucleic acid amplification test (NAAT) technology and a single collection device, the Aptima Multitest Swab simplifies testing and provides more answers for sexual and vaginal health.

Aptima® CMV Quant Assay

FDA-Approved solution to reliably and efficiently deliver actionable viral load insights to post-transplant patients and their care teams.  

Aptima® HBV Quant Assay

Deliver trusted results with dual targets across a wide linear range and all major HBV genotypes.

Aptima® HCV Quant Dx Assay

Confirmation of active HCV infection and monitoring HCV viral load on the fully automated Panther® system.  

Aptima® Herpes Simplex 1 & 2 assay

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3
Aptima® HIV-1 Quant Dx Assay

Aptima® HIV-1 Quant Dx Assay

HIV-1 Detection and Viral Load Monitoring With performance you can count on, the Aptima HIV-1 Quant Dx assay is a dual-claim assay that can be used to confirm HIV-1 infection and measure viral load for optimal patient management.1 It offers reliable quantitation of HIV-1 RNA across a broad linear range, giving your lab excellent precision and sensitivity for HIV-1 detection and viral load monitoring.

Aptima® HIV-1 Quant Dx Assay

Dual-claim assay to confirm HIV-1 infection and measure viral load.
 

Aptima® HPV +ThinPrep® Cervical Health

Cervical disease screening is an essential component of our efforts in women’s health. Hologic is the leader in Pap and human papillomavirus (HPV) testing. The ThinPrep Pap test helps healthcare providers and laboratory professionals detect the presence of abnormal cervical cells, and the Aptima HPV assays identify high-risk HPV mRNA that is indicative of the HPV infections most likely to lead to cervical disease.1-3  

Know the Facts

The Pap test has been the most successful cancer screening program in history.4

The rate of cervical cancer, which was a leading cause of death among women, has fallen by more than 70 percent since the Pap test was introduced over 80 years ago.5 Previously, cervical cancer was the leading cause of cancer death in women, but now it is the fifteenth most frequent.

Reducing cervical cancer incidence requires a comprehensive strategy.

Such a strategy will include screening options that take into account disparities that underserved women face. This strategy should focus on reducing preventive screening gaps by:

  • Implementing provider and patient education
  • Providing access to vaccinations
  • Offering Pap + HPV (co-testing)

Aptima® STIs

STI testing for improved sexual health. The Aptima STI portfolio supports sexual health testing with a comprehensive, flexible menu of sexually transmitted infection (STI) assays.

   

Aptima® Trichomonas vaginalis assay

Trichomonas vaginalis (TV) is the most common curable STI in the United states.1 Over 3.7 million people in the United States have TV, which is a higher prevalence than chlamydia and gonorrhea infections combined.1 The CDC recommends testing women for TV infection if they are symptomatic or at increased risk of infection.2 The CDC and ACOG also recommend the use of a highly sensitive and specific test, such as the Aptima® Trichomonas vaginalis assay.2,3

Aptima® Vaginal Health

The Aptima vaginitis panel from Hologic consists of molecular nucleic acid amplification tests (NAAT) to aid in the detection of vaginosis and vaginitis. Our assays detect the three most common causes of infectious vaginitis: bacterial vaginosis, candida vaginitis and trichomoniasis.

Aptima® Virology

The Aptima Virology portfolio delivers on the Hologic promise of innovation through life-changing viral testing for viruses that impact patients across the globe.

Diagnostic Collection Devices and Transfer Tubes

Consolidate testing with direct load collection devices. With a simplified workflow, market-leading diagnostic tests and scalable automation, you can trust Hologic as your long term testing partner.

Direct Load Capture Cap Collection Kit

Transform specimen processing with the only nasopharyngeal (NP) swab that loads directly for COVID testing.

No specimen transferExpedite your SARS-CoV-2* workflow with a collection device that loads directly on the Panther® system.  The Direct Load Capture Cap Collection Kit is authorized for use with the Aptima® SARS-CoV-2 and Aptima SARS-CoV-2/Flu assays.
Loading...